3Chopt Investment Partners LLC Has $333,000 Holdings in Colgate-Palmolive Company $CL

3Chopt Investment Partners LLC cut its position in shares of Colgate-Palmolive Company (NYSE:CLFree Report) by 13.0% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,664 shares of the company’s stock after selling 548 shares during the quarter. 3Chopt Investment Partners LLC’s holdings in Colgate-Palmolive were worth $333,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of CL. Brighton Jones LLC increased its position in shares of Colgate-Palmolive by 4.4% during the fourth quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock worth $962,000 after buying an additional 450 shares during the period. Park Avenue Securities LLC increased its position in shares of Colgate-Palmolive by 15.7% during the first quarter. Park Avenue Securities LLC now owns 9,989 shares of the company’s stock worth $936,000 after buying an additional 1,356 shares during the period. Pallas Capital Advisors LLC grew its holdings in Colgate-Palmolive by 15.3% in the first quarter. Pallas Capital Advisors LLC now owns 3,822 shares of the company’s stock worth $358,000 after purchasing an additional 508 shares during the period. Harbor Capital Advisors Inc. grew its holdings in Colgate-Palmolive by 7.2% in the first quarter. Harbor Capital Advisors Inc. now owns 14,879 shares of the company’s stock worth $1,394,000 after purchasing an additional 1,005 shares during the period. Finally, Wealthcare Advisory Partners LLC grew its holdings in Colgate-Palmolive by 10.0% in the first quarter. Wealthcare Advisory Partners LLC now owns 4,411 shares of the company’s stock worth $413,000 after purchasing an additional 402 shares during the period. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

CL has been the subject of a number of research reports. Bank of America reduced their price target on shares of Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating for the company in a report on Wednesday. JPMorgan Chase & Co. reduced their price target on shares of Colgate-Palmolive from $95.00 to $88.00 and set an “overweight” rating for the company in a report on Friday. UBS Group reduced their price target on shares of Colgate-Palmolive from $99.00 to $92.00 and set a “buy” rating for the company in a report on Wednesday. Citigroup reduced their price target on shares of Colgate-Palmolive from $108.00 to $105.00 and set a “buy” rating for the company in a report on Monday, August 4th. Finally, The Goldman Sachs Group reduced their price target on shares of Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating for the company in a report on Thursday, October 2nd. Eight research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $92.21.

View Our Latest Report on CL

Colgate-Palmolive Trading Up 0.2%

CL opened at $77.99 on Friday. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57. Colgate-Palmolive Company has a fifty-two week low of $77.09 and a fifty-two week high of $102.61. The firm has a market capitalization of $63.03 billion, a PE ratio of 21.91, a P/E/G ratio of 4.28 and a beta of 0.34. The company’s 50-day moving average is $82.56 and its 200 day moving average is $87.91.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its earnings results on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, topping analysts’ consensus estimates of $0.89 by $0.03. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The company had revenue of $5.11 billion for the quarter, compared to analyst estimates of $5.03 billion. During the same quarter in the prior year, the business posted $0.91 EPS. The firm’s revenue was up 1.0% compared to the same quarter last year. As a group, research analysts predict that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 17th will be issued a dividend of $0.52 per share. The ex-dividend date is Friday, October 17th. This represents a $2.08 annualized dividend and a yield of 2.7%. Colgate-Palmolive’s payout ratio is 58.43%.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Articles

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.